In vitro and in vivo evaluation of novel cationic liposomes utilized for cancer gene therapy

Journal of Controlled Release

Volumn 113, Issue 3, 2006, Pages 255-260

  Serikawa, Takehiro ^a   Kikuchi, Akira ^a   Sugaya, Susumu ^a   Suzuki, Norio ^b   Kikuchi, Hiroshi ^b   Tanaka, Kenichi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

Ascitic mice; Cationic liposomes; Human cancer cells; Serum; Suicide gene therapy

Indexed keywords

ASSAYS; CELL CULTURE; ENZYMES; GENETIC ENGINEERING; TUMORS;

ASCITIC MICE; CATIONIC LIPOSOMES; HUMAN CANCER CELLS; SERUM; SUICIDE GENE THERAPY;

ONCOLOGY;

BETA GALACTOSIDASE; CATION; GANCICLOVIR; HERPES SIMPLEX VIRUS THYMIDINE KINASE; LIPOSOME; O,O' DITETRADECANOYL N (ALPHA TRIMETHYLAMMONIOACETYL)DIETHANOLAMINE CHLORIDE DIOLEYLPHOSPHATIDYLETHANOLAMINE LIPOSOME COMPLEX; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASCITES; CANCER CELL; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CONTROLLED STUDY; CULTURE MEDIUM; ENDOMETRIUM CANCER; FEMALE; GENE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KAPLAN MEIER METHOD; LACZ GENE; MOUSE; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OVARY CANCER; PRIORITY JOURNAL; SERUM; SUICIDE GENE THERAPY; SURVIVAL TIME;

ANIMALS; ANTINEOPLASTIC AGENTS; CATIONS; CELL LINE, TUMOR; CELL SURVIVAL; COMBINED MODALITY THERAPY; ETHANOLAMINES; FEMALE; GANCICLOVIR; GENE THERAPY; GENES, REPORTER; HUMANS; INHIBITORY CONCENTRATION 50; LAC OPERON; LIPOSOMES; MICE; MICE, NUDE; MYRISTATES; NEOPLASM TRANSPLANTATION; OVARIAN NEOPLASMS; PHOSPHATIDYLETHANOLAMINES; SIMPLEXVIRUS; THYMIDINE KINASE; TRANSFECTION;

EID: 33745511942     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2006.04.001     Document Type: Article

References (31)

1. Loggie B.W., Fleming R.A., Mcquellon R.P., Russell G.B., and Geisinger K.R. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am. Surg. 66 (2000) 561-568
2. Verma I.M., and Weitzman M.D. Gene therapy: twenty-first century medicine. Ann. Rev. Biochem. 74 (2005) 711-738
3. Yoshida T., Ohnami S., and Aoki K. Development of gene therapy to target pancreatic cancer. Cancer Sci. 95 (2004) 283-289
4. Lechanteur C., Delvenne P., Princen F., Lopez M., Fillet G., Gielen J., Merville M.P., and Bours V. Combined suicide and cytokine gene therapy for peritoneal carcinomatosis. Gut 14 (2000) 343-348
5. Denning C., and Pitts J.D. Bystander effects of different enzyme-prodrug system for cancer gene therapy depend on different pathways for intracellular transfer of toxic metabolites, a factor that will govern clinical choice of appropriate regimes. Hum. Gene Ther. 8 (1997) 1825-1835
6. Esandi M.C., Van Someren G.D., Vincent A.J.P.E., Van Bekkum D.W., Valerio D., Bout A., and Noteboom J.L. Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene. Gene Ther. 4 (1997) 280-287
7. Wu N., and Ataai M.M. Production of viral vectors for gene therapy applications. Curr. Opin. Biotechnol. 11 (2000) 205-208
8. Ledley F.D. Nonviral gene therapy: the promise of genes as pharmaceutical products. Hum. Gene Ther. 6 (1995) 1129-1144
9. Wigler M., Silverstein S., Lee L.S., Pellicer A., Cheng Y.C., and Axel R. Transfer of purified herpes virus thymidine kinase gene to cultured mouse cell. Cell 11 (1977) 223-232
10. Ishikawa Y., and Homcy C.J. High efficiency gene transfer into mammalian cells by a double transfection protocol. Nucleic Acids Res. 20 (1992) 4367
11. Paquereau L., and Cam A.L. Electroporation-mediated gene transfer into hepatocytes: preservation of a growth hormone response. Anal. Biochem. 204 (1992) 147-151
12. Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.W., Wenz M., Northrop J.P., and Ringold G.M. Lipofectin: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 7413-7417
13. Zabner J., Fasbender A.I.J., Moninger T., and Poellinger K.A. Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. 270 (1995) 18997-19007
14. Felgner P.L., and Ringold G.M. Cationic liposome-mediated transfection. Nature 337 (1989) 387-388
15. Kikuchi A., Aoki Y., Sugaya S., Serikawa T., Takakuwa K., Tanaka K., Suzuki N., and Kikuchi H. Development of novel cationic liposomes for efficient gene transfer into peritoneal disseminated tumor. Hum. Gene Ther. 10 (1999) 947-955
16. Kikuchi Y., Kizawa I., Oomori K., et al. Establishment of a human ovarian cancer cell line capable of forming ascites in nude mice and effects of tranexamic acid on cell proliferation and ascites formation. Cancer Res. 47 (1987) 592-596
17. Kikuchi Y., Iwano I., and Kato K. Effects of calmodulin antagonists on human ovarian cancer cell proliferation in vitro. Biochem. Biophys. Res. Commun. 123 (1984) 385-392
18. Lau D.H.M., Ross K.L., and Sikic B.I. Paradoxical increase in DNA cross-linking in a human ovarian carcinoma cell line resistant to cyanomorpholino doxorubicin. Cancer Res. 50 (1990) 4056-4060
19. Fogh J., Wright W.C., and Loveless J.D. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J. Natl. Cancer Inst. 58 (1977) 209-214
20. Fogh J., Fogh J.M., and Orfeo T. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J. Natl. Cancer Inst. 59 (1977) 221-226
21. Sakamoto H., Deng X., Shirakawa T., Ige S., Ohtani K., Saitoh A., Takami M., and Satoh K. Establishment of metastatic sub-clone from estrogen independent Ishikawa cells and its characterization in vitro and in vivo. Acta Obstet. Gynaecol. Jpn. 47 (1995) 249-256
22. Nishida M., Kasahara K., Kaneko M., and Iwasaki H. Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors. Acta Obstet. Gynaecol. Jpn. 37 (1985) 1103-1111
23. Gao X., and Huang L. Cationic liposome-mediated gene transfer. Gene Ther. 2 (1995) 710-722
24. Niwa H., Yamamura K., and Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108 (1991) 193-200
25. Mcknight S.L., and Gavis E.R. Expression of the herpes thymidine kinase gene in Xenopus laevis oocytes: an assay for the study of deletion mutants constructed in vivo. Nucleic Acids Res. 8 (1980) 5931-5948
26. Sugaya S., Fujita K., Kikuchi A., Ueda H., Takakuwa K., Kodama S., and Tanaka K. Inhibition of tumor growth by direct intratumoral gene transfer of herpes simplex virus thymidine kinase gene with DNA-liposome complexes. Hum. Gene Ther. 7 (1996) 223-230
27. Denizot F., and Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 87 (1986) 271-277
28. Li S., and Huang L. Nonviral gene therapy: promises and challenges. Gene Ther. 7 (2000) 31-34
29. Hyde S.C., Southern K.W., Gileadi U., Fitzjohn E.M., Mofford K.A., Waddell B.E., Gooi H.C., Goddard C.A., Hannavy K., Smyth S.E., Egan J.J., Sorgi F.L., Huang L., Cuthbert A.W., Evans M.J., Colledge W.H., Higgins C.F., Webb A.K., and Gill D.R. Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis. Gene Ther. 7 (2000) 1156-1165
30. Serikawa T., Suzuki N., Kikuchi H., Tanaka K., and Kitagawa T. A new cationic liposome for efficient gene delivery with serum into cultured human cells: a quantitative analysis using two independent fluorescent probes. Biochim. Biophys. Acta 1467 (2000) 419-430
31. Mesnil M., and Yamasaki H. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. Cancer Res. 60 (2000) 3989-3999